Navigation Links
Vitros 250 Chemistry System

ProductsVitros 250 Chemistry System
Company Ortho-Clinical Diagnostics
Item Vitros 250 Chemistry System
Features 
  • No preparation of reagents for use
    Minimal interference from hemolysis
  • Lipemia & bilirubin
  • Small sample size requirements
  • Up to 250 results per hour
  • On-board capacity for all assays
  • Primary tube sampling
  • Open architecture design for use with laboratory automation systems
  • Easy to use touchscreen operator interface
  • Flexible processing for manual, stat or automated testing
Description The Vitros 250 is a flexible system that can meet requirements in multiple environments small hospitals, backup in large hospitals, clinics and satellite locations. The Vitros 250 also features on-board dilution, and can be automated or placed in a workcell.
Info Ortho-Clinical DiagnosticsCall Ortho-Clinical Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-802-9580

Customer Service: 1-800-828-6316
Web site: http://www.orthoclinical.com

Related medicine products :

1. Vitros 950 Chemistry System
2. Vitros DT60 II Chemistry System
3. Vitros Eci
4. Aeroset Clinical Chemistry System
5. Advia 1650 Chemistry System
6. Advia 2400 Chemistry System
7. Express Plus Clinical Chemistry Analyzer
8. Dimension RxL Max™ Integrated Chemistry System 50/60HZ
9. Dimension RxL Max™ Integrated Chemistry System
10. Dimension Xpand Plus Integrated Chemistry System
11. Semi-Automated Chemistry Analyzer
WEBeDoctor® Physician-office® is an internet productivity tool for physicians, (Solo practice, group practice and managed care), to complete their normal duties in a practice. It is a front
...the core applications for health information manag...ical record. The suite includes applications for c...letion & release of information., Implemented...HARMS 2000 modules leverage the most sophisticated...
...ts, Care Management, I/O, Flow Sheets, Medication ...nd Therapies are accessible. Vitals and other peri...of care on a wireless handheld terminal so the com...mmary gives longitudinal view of patients health s...
...s a subscription-based service, which enables you ...tware without purchasing or maintaining the electr...r server. All you need is a broadband Internet con...o connect to your patient medical record database;...
Medicine Products:
(Date:7/25/2008)...oducts reduces lung function, increases asthma ris...(HealthDay News) -- A clean, fresh-smelling home m...hat type of cleaning and air freshening products y...e to cleaning products or air fresheners that cont...ed 1,4 dicholorobenzene (1,4 DCB), can reduce lung...
(Date:7/25/2008)...Though the number of jobs created in the medical f...rted a different kind of slowdown: they laid off f... Seattle, WA (PRWEB) July 25,...medical field slowed in June overall, pharmaceutic... that will be music to the ears of sales represent...
(Date:7/25/2008)...on Executive, Robert J. Reilly, Joins Aethon Team,...( http://www.aethon.com ), the leading developer o...ics, today announced that Robert J. Reilly has,joi...Financial Officer., Reilly, who was most recently...rporation,s Specialty Pharmacy Division, brings mo...
(Date:7/25/2008)...in esophagus can cause immune system changes , ...irst evidence linking gastroesophageal reflux dise...University Medical Center researchers. , An ass...d in the 1970s, and since then studies have shown ...atients also experience GERD symptoms. But the act...
Breaking Medicine News(10 mins):Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:People With GERD More Likely to Develop Asthma 2
...ecent research it was found that teenagers who wer...s to other hard drugs// later in their life. Teen...ife due to the positive emotion that they derive b...dered to be the gateway drug which further leads a...
...al clefting leaves some with psychological problem...t of oral clefting on quality of life can be used ...st effectiveness of prevention and treatment. Or...birth defects. The impact of oral clefting can be ...
...roven to significantly improve the vision of elder...The drug, Lucentis, is to treat age-related macula...s behind the retina leak, worsening vision and oft... the 1.4 million Americans, who have lost their vi...
... the University of Melbourne are claiming that the...such as diabetes and multiple sclerosis in humans/...elbourne have enlisted 100 domestic dogs in their ...etic make-up, causes diseases. The researchers aim...
Other Medicine News:Health News:Learning the Value of Prevention and Treatment in Oral Clefting 2Health News:DNA Of Dog Could Hold The Key To Combat Human Diseases. 2
(Date:7/22/2008)...rom a multi-center 293-patient European, trial -,...ge Symbol: CYT, MONTREAL, July 22 /PRNewswire-Fir...l leader in cryotherapy products to treat cardiac,...ly presented from three,European study centers usi...re published earlier today in the Journal of the A...
(Date:7/22/2008)...ty and Efficacy of Treating Patients with ...SCO, and YONGIN-SI, South Korea, July 22 /PRNewswi...a, Ontario), and its South,Korean partner Green Cr...m,a Phase I clinical trial of its first-in-class l...as well-tolerated and resulted in clear,anti-cance...
(Date:7/22/2008)..., July 22 /- Hyperion,Therapeutics, I...enrollment,in its Phase 1/2 clinical trial to eval...ng effects of HPN-100 (formally called GT4P) versu...with urea cycle disorders,(UCD). The company plans...r,of this year., (Logo: http://www.newscom.com/c...
(Date:7/22/2008)...uly 22 /- NicOx S.A.,(Euron...y completed the,enrollment of 417 osteoarthritis (...linical pharmacology studies in the United States,...e trials are designed to assess the,blood pressure...n and,naproxen, using the Ambulatory Blood Pressur...
Breaking Medicine Technology:CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 2NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients 3NSF International Acquires David Begg Associates 460 1NSF International Acquires David Begg Associates 460 2Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 1Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 2Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 3Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 4Aware Celebrates Fifteen Years of Innovation and Leadership in the Biometrics Industry 456 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 1Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 224 44 000 e Books now available on ScienceDirect 314 14 000 e Books now available on ScienceDirect 314 2
.../PRNewswire/ -- Results from analyses,looking at...,ulcerative colitis (UC), were presented at Digest...studies were funded by Procter &,Gamble (P&G) Ph...r new information on improvement of quality of lif...mine), which is from a class,of agents known as ...
... 2007 /PRNewswire/ -- A three-year,follow-up sub...clinical trial at EuroPCR 2007 showed that the CYP...lts comparable to coronary,artery bypass graftin...han bare metal stents (BMS) in diabetic patients w..., The CYPHER(R) Stent results in the diabetic po...
Other Medicine Technology:Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 2Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 3Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 4Separate Sets of Research Show Treatment Improved Quality of Life,in as Early as Three Weeks; Patient Adherence to Medication is,Multifactorial 5Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 2Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 4